Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)

Lignende værker

• Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)
  af: Le-Petross, Huong T., et al.
  Udgivet: (2018)
• Identification and resection of the clipped node decreases the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy – results from ACOSOG Z1071 (Alliance)
  af: Boughey, Judy C., et al.
  Udgivet: (2016)
• Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial
  af: Boughey, Judy C., et al.
  Udgivet: (2014)
• Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance)
  af: Boughey, Judy C., et al.
  Udgivet: (2015)
• LYMPHEDEMA SYMPTOMS AND LIMB MEASUREMENT CHANGES IN BREAST CANCER SURVIVORS TREATED WITH NEOADJUVANT CHEMOTHERAPY AND AXILLARY DISSECTION: RESULTS OF ACOSOG (AMERICAN COLLEGE OF SURGEONS ONCOLOGY GROUP) Z1071 (ALLIANCE) SUBSTUDY
  af: Armer, Jane M., et al.
  Udgivet: (2018)